Ropinirole 2mg tablets — Class II drug recall D-0499-2023
Terminated recall by RemedyRepack Inc., reported 2023-04-12, distributed nationwide. cGMP Deviations
| Recall number | D-0499-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | RemedyRepack Inc., Indiana, PA, United States |
| Recall initiated | 2023-03-20 |
| Classified | 2023-03-31 |
| Reported by FDA | 2023-04-12 |
| Terminated | 2023-10-19 |
| Distributed | Nationwide (US) |
| Quantity | 3 bottles |
| Reason classes | cgmp |
| NDC | 70518-2750-00 |
| Lot numbers | B1630017-040122 |
| Expiration dates | 2023-04-30 |
Product
Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC70518-2750-00
Reason for recall
cGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0499-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.